Ambrisentan is an oral, once-daily endothelin receptor antagonist that is selective for the endothelin type A receptor (IC50s = 0.251, 0.316, 0.398, 251, and 630 nM for rat preparations of heart, bladder, kidney, lung, and cerebral cortex, respectively).
More Information Supplier Page
Trifluorothymidine is a derivative of thymidine that can inhibit thymidylate synthase and lead to DNA damage and apoptosis. It could be used to treat colorectal cancer.
More Information Supplier Page
Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone and it is a promising compound for the therapy and prophylaxis of all forms of theileriosis.
More Information Supplier Page
Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone and it is a promising compound for the therapy and prophylaxis of all forms of theileriosis.
More Information Supplier Page 
Butyl 4-hydroxybenzoate is an organic compound, has proven to be a highly successful antimicrobial preservative in cosmetics, also used in medication suspensions, and as a flavoring additive in food.
More Information Supplier Page
Butyl 4-hydroxybenzoate is an organic compound, has proven to be a highly successful antimicrobial preservative in cosmetics, also used in medication suspensions, and as a flavoring additive in food.
More Information Supplier Page 
Butenafine HCl is a synthetic benzylamine antifungal targeting on squalene epoxidase working by inhibiting the synthesis of ergosterol needed in fungal cell membranes.
More Information Supplier Page
Butenafine HCl is a synthetic benzylamine antifungal targeting on squalene epoxidase working by inhibiting the synthesis of ergosterol needed in fungal cell membranes.
More Information Supplier Page 
